Thermo Fisher Scientific Inc.TMONYSE
LOADING
|||
EBITDA Over Time
Above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$11.80B
↑ 41% above average
Average (9y)
$8.36B
Historical baseline
Range
High:$11.97B
Low:$4.04B
CAGR
+12.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $11.80B | +5.4% |
| 2023 | $11.20B | -6.3% |
| 2022 | $11.94B | -0.2% |
| 2021 | $11.97B | +18.4% |
| 2020 | $10.11B | +43.9% |
| 2019 | $7.02B | +13.4% |
| 2018 | $6.20B | +22.6% |
| 2017 | $5.05B | +18.9% |
| 2016 | $4.25B | +5.2% |
| 2015 | $4.04B | - |